EP2574341
Árangursrík meðhöndlun æxla og krabbameins með trísíríbínfosfati
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
29.3.2005EP published:
29.3.2017EP application number:
12197499.2
EP translation filed:
12.6.2017Grant published:
15.7.2017EPO information:
European Patent Register
Max expiry date:
28.3.2025Expiry date:
28.3.2024
Title:
Effective treatment of tumors and cancer with triciribine phosphate
Timeline
Today
29.3.2005EP application
29.3.2017EP Publication
12.6.2017Translation submitted
15.7.2017Registration published
28.3.2024Expires
Owner
Name:
UNIVERSITY OF SOUTH FLORIDAAddress:
3702 Spectrum Blvd, Suite 155, 33612, Tampa, FL, US
Inventor
Name:
Cheng, Jin Q.Address:
Tampa, FL Florida, US
Name:
Sebti, Said M.Address:
Tampa, FL Florida, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
557599 PDate:
29.3.2004Country:
US
Classification
Categories:
A61K 31/7064, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 22.6.2017
Expires: 28.3.2018
Payer: Árnason Faktor
Number: 14
Paid: 14.3.2018
Expires: 28.3.2019
Payer: Árnason Faktor
Number: 15
Paid: 13.2.2019
Expires: 28.3.2020
Payer: Árnason Faktor
Number: 16
Paid: 24.1.2020
Expires: 28.3.2021
Payer: Árnason Faktor ehf.
Number: 17
Paid: 15.1.2021
Expires: 28.3.2022
Payer: Árnason Faktor ehf.
Number: 18
Paid: 16.3.2022
Expires: 28.3.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 27.3.2023
Expires: 28.3.2024
Payer: Árnason Faktor ehf.